´ëÇÑÆó¾ÏÇÐȸ 2018 KALC International Conference : 2018-11-24 ±³À°ÀÏÀÚ : 2018-11-24 ±³À°Àå¼Ò : ¼¿ïƯº°½Ã Àá½Ç ·Ôµ¥È£ÅÚ¿ùµå 3Ãþ Å©¸®½ºÅ»º¼·ë(¿Ü 1°³·ë) ±³À°ÁÖÁ¦ : 2018 KALC International Conference ÁÖÃÖ±â°ü : ´ëÇÑÆó¾ÏÇÐȸ ´ã´çÀÚ : ¹æÀ¯Áø ¿¬¶ôó : 02-6711-4767 À̸ÞÀÏ : youjin@medrang.co.kr ±³À°Á¾·ù : ³»°ú, ÈäºÎ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú, ÇÙÀÇÇаú Âü¼®¿¹»óÀοø : 600¸í Èñ¸ÁÆòÁ¡ : 6Á¡ Áö¿ª : ¼¿ïƯº°½Ã ±³À°½Ã°£ : 8 ½Ã°£ 0ºÐ ¼¼ºÎ¼ö°·á : 300,000¿ø ºñ°í 30¸¸¿ø(Àü¹®ÀÇ, ±³¼ö) 25¸¸¿ø(Æç·Î¿ì, Àü°øÀÇ, °£È£»ç µî)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ ±³À°½Ã°£ 11-24 Crystal 1 07:50~08:30 Optimal Treatment Sequence in EGFR Targeted Therapy with Long Term Perspective Maximilian J. Hochmair(Otto Wagner Hospital, Vienna, Austria) ±³À°½Ã°£ 11-24 Crystal 2 07:50~08:30 New Target Agent: Dabrafenib Plus Trametinib in Patients with BRAF Mutant Metastatic Non-Small Cell Lung Cancer James Chung-man Ho(The University of Hong Kong, Hong Kong) ±³À°½Ã°£ 11-24 Crystal 3 07:50~08:30 The Evolving Power of Immunotherapy : Tecentriq in Advanced Lung cancer Takashi Seto(National kyushu cancer center, Japan) ÈÞ½Ä 11-24 08:30~09:00 Coffee Break () ±³À°½Ã°£ 11-24 Crystal 1,2,3 09:00~09:30 Basic Perspective for Immunotherapy in Lung Cancer Eui Cheol Shin(KAIST, Korea) ±³À°½Ã°£ 11-24 Crystal 1,2,3 09:30~10:00 Clinical Perspective for Current Immunotherapy in NSCLC Michael Boyer(Chris O¡¯Brien Lifehouse, Australia) ±³À°½Ã°£ 11-24 Crystal 1,2,3 10:00~10:30 Beyond PD-l/PD-L1 Inhibitor: New Targeted Immunotherapy or Combination Therapy Tien Hoang(Genentech, USA) ÈÞ½Ä 11-24 10:30~11:00 Coffee Break () ±³À°½Ã°£ 11-24 Crystal 1,2 11:00~11:30 The Value Proposition of Liquid Biopsies to Precision Medicine Richie Soong(Yong Loo Lin School of Medicine, Singapore) ±³À°½Ã°£ 11-24 Crystal 3 11:00~11:30 The Clinical Correlation of the 8th AJCC Staging System in Lung Adenocarcinoma Focusing on Early Stage Patients: Taiwan Experience Shiu-Feng Huang(Institute of Molecular and Genomic Medicine, Taiwan) ±³À°½Ã°£ 11-24 Emerald 11:00~11:30 Korean Lung Cancer Screening Project: Initial Results Hyae Young Kim(National Cancer Center, Korea) ±³À°½Ã°£ 11-24 Crystal 1,2 11:30~12:00 Liquid Biopsy Successfully Detects Best Drugs for Treating Lung Cancer James Yang(National Taiwan University Hospital, Taiwan) ±³À°½Ã°£ 11-24 Crystal 3 11:30~12:00 Lung Cancers with Multiple Pulmonary Sites of Involvement in the Eighth Edition of the TNM Classification Hyo Sup Shim(Yonsei Univ., Korea) ±³À°½Ã°£ 11-24 Emerald 11:30~12:00 Lung Cancer Screening: European Experience Matthijs Oudkerk(NELSON, Netherlands) ±³À°½Ã°£ 11-24 Crystal 1,2 12:00~12:30 Extracellular Vesicles(EV)-derived DNA for Liquid Biopsy in Lung Cancer Kye Young Lee(Konkuk Univ., Korea) ±³À°½Ã°£ 11-24 Crystal 3 12:00~12:30 Clinical Significance of New WHO Classification of Lung Cancer Hironori Ninomiya(The Cancer Institute Hospital of Japanese Foundation For Cancer Research, Japan) Åä·Ð 11-24 Emerald 12:00~12:30 Question and Answer ()
|